MEDANTA - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 4.0

MEDANTA is in a strong technical trend with solid profitability metrics, making it an attractive candidate for swing trading. However, its high valuation and recent profit tapering suggest a strategic entry is essential to avoid chasing.

📊 Fundamental Breakdown

Valuation

P/E: 69.2 → Matches Industry PE, high but normalized for sector

PEG Ratio: 1.81 → Reasonable growth valuation

EPS: ₹17.9, Book Value: ₹126 → High price-to-book ratio

Profitability

ROCE: 19.5%, ROE: 16.5% → Healthy returns on capital

PAT Qtr: ₹137 Cr. vs ₹143 Cr. → Slight dip, still consistent

Balance Sheet

Debt-to-equity: 0.21 → Low leverage

Dividend Yield: 0.00% → Not relevant for swing entry

Institutional Sentiment

Minor shift: FII ↓ 0.22%, DII ↑ 0.27%

📈 Technical Profile

Price Action

Current Price ₹1,331 above

DMA 50: ₹1,246

DMA 200: ₹1,183 → Momentum continuation pattern

Momentum Indicators

RSI: 62.9 → Bullish zone, slightly heated

MACD: 36.3 → Strong bullish crossover

Volume: 3.33L vs Avg 3.5L → Slight drop, needs watch

52W Index: 86.5% → Near high of ₹1,393; breakout watch

🧭 Swing Trade Strategy

✅ Optimal Entry Zone

Buy Range: ₹1,290–₹1,315 Enter near last breakout base & below RSI cooling zone

Consider staged entry as price revisits 50-DMA area for better control.

🚪 Exit Plan

Target Range: ₹1,375–₹1,390 Near 52-week high — trail profits as resistance nears.

Stop-Loss: ₹1,250 Below 50-DMA and breakout support.

💡 Already Holding?

You're in a strong setup — RSI and MACD support upside.

Look to trim near ₹1,375+, especially if RSI hits 70+ and MACD flattens.

If price dips below ₹1,280 without volume support, consider partial exit.

Would you like to explore similar healthcare plays with stronger growth signals or better valuation spreads? I've got a few lined up that might suit your strategy.

Edit in a page